Virtual Medicinal Product (VMP) - Fostamatinib 150mg tablets
Name Details
| Name | Start Date | End Date | |
|---|---|---|---|
| Name | Current Name Fostamatinib 150mg tablets | Start Date 19-06-2020 | End Date |
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- tablet
- Unit Dose UOM
- tablet
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral tablet
- Ontology Form/Route
- tablet.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
- B02BX09
| Code | Start Date | End Date |
|---|---|---|
| 38716611000001101 | 19-06-2020 |
VMP Ingredients
| Name | Basis of Strength Description | BOSS | Strength and UOM (Nmr) | Strength and UOM (Dmr) |
|---|---|---|---|---|
| Fostamatinib disodium hexahydrate | Based on Base Substance | Fostamatinib | 150 mg |
Name
Fostamatinib disodium hexahydrate
Basis of strength description
Based on Base Substance
BOSS
Fostamatinib
Strength and UOM (Nmr)
150.0
Strength and UOM (Dmr)
Parent Products
-
VTMFostamatinib
-
VMP(Current) Fostamatinib 150mg tablets
-
AMP
-
-
Virtual Medicinal Product Pack (VMPP) Information
| Pack Size | Drug Tariff Price | Drug Tariff Payment Category |
|---|---|---|
| 60 tablet |